As a broad-spectrum antimicrobial peptide without drug resistance, defensin has great potential for developing new natural antimicrobial treatments for reproductive tract infections. However, increasing evidence has shown that defensins can not only inhibit microbial invasion but can also promote the invasion and adhesion of some microorganisms in certain biological environments, such as human immunodeficiency virus. Therefore, the safety of defensins as reproductive tract anti-infective drugs needs more in-depth research. In addition, the modulatory role of defensins in fertility requires more in-depth research since the current conclusions are based on small-size samples. At present, scientists have made many attempts at the clinical transformation of defensins. However, defensins have problems such as poor stability, low bioavailability and difficulties in their synthesis. Therefore, the production of safe, effective and low-cost drugs remains a challenge.
Keyphrases
- human immunodeficiency virus
- low cost
- cell migration
- hepatitis c virus
- endothelial cells
- antiretroviral therapy
- optical coherence tomography
- mental health
- hiv infected
- microbial community
- escherichia coli
- cystic fibrosis
- risk assessment
- induced pluripotent stem cells
- human health
- childhood cancer
- pluripotent stem cells